National Cancer Institute Notice of Closed Meetings, 54301 [2015-22659]
Download as PDF
Federal Register / Vol. 80, No. 174 / Wednesday, September 9, 2015 / Notices
Lhorne on DSK5TPTVN1PROD with NOTICES
health utility in combating the
development and spread of antibiotic
resistant bacteria. A prioritized list of 18
bacteria of highest concern can be found
in Table 3 of the National Action Plan
(https://www.whitehouse.gov/sites/
default/files/docs/national_action_
plan_for_combating_antibotic-resistant_
bacteria.pdf). Input received from the
RFI and during the public consultation
will be used by HHS to develop the
technical criteria and performance
characteristics of the diagnostic(s) for
which the prize(s) will be offered. The
design of the Challenge will take into
account previous guidance obtained in
the aforementioned National Strategy
and National Action Plan to combat
antibiotic resistant bacteria.
The agenda of the public consultation
meeting will be devoted to presentations
and discussions on the objectives and
criteria for the antimicrobial diagnostic
challenge competition. Presentations
will focus on the need for rapid
diagnostics to address antimicrobial
resistance; development and use of
rapid diagnostics for drug resistant
microorganisms; pathogen/resistance
markers identification versus
phenotypic susceptibility; antibiotic
stewardship in the clinical setting; and
regulatory perspectives on rapid
diagnostic development.
Any interested person may submit
written comments to be considered
during the public consultation to the
discussion board for this Challenge
accessible on https://
www.challenge.gov. This statement
should include your name, address,
telephone number and when applicable,
the business or professional affiliation.
Written comments can be submitted
from October 1, 2015 at 8:30 a.m. EDT
to October 6, 2015 at 5:00 p.m. EDT.
This web-based discussion board also
provides an open forum for discussion
of this prize competition. The online
community is open to the public and
will allow for a broad and interactive
discussion of the topics covered by this
public consultation. This platform will
allow users to submit ideas about a
desired diagnostic test and to comment
on the ideas that have been submitted
by others.
Dated: September 1, 2015.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
[FR Doc. 2015–22690 Filed 9–8–15; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
14:19 Sep 08, 2015
Jkt 235001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Omnibus R03 & R21 SEP–8.
Date: October 27–28, 2015.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Yisong Wang, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W240, Rockville, MD
20850, 240–276–7157, yisong.wang@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Omnibus R03 & R21 SEP–11.
Date: October 29, 2015.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hilton Hotel Bethesda,
8120 Wisconsin Avenue, Bethesda, MD
20814.
Contact Person: Reed A. Graves, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W264, Rockville, MD 20850,
240–276–6384, gravesr@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Omnibus R03 & R21 SEP–3.
Date: November 5–6, 2015.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Viatcheslav A.
Soldatenkov, MD, Ph.D., Scientific Review
Officer, Special Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
54301
Room 7W254, Bethesda, MD 20892, 240–
276–6378, soldatenkovv@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Omnibus R03 & R21 SEP–1.
Date: November 9–10, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hilton Hotel Bethesda,
8120 Wisconsin Avenue, Bethesda, MD
20814.
Contact Person: Zhiqiang Zou, MD, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W242, Bethesda, MD
20892–8328, 240–276–6372, zouzhiq@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: September 3, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–22659 Filed 9–8–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Time-Sensitive
Obesity.
Date: September 30, 2015.
Time: 1 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\09SEN1.SGM
09SEN1
Agencies
[Federal Register Volume 80, Number 174 (Wednesday, September 9, 2015)]
[Notices]
[Page 54301]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-22659]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI Omnibus R03 & R21 SEP-8.
Date: October 27-28, 2015.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Yisong Wang, Ph.D., Scientific Review Officer,
Special Review Branch, Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W240,
Rockville, MD 20850, 240-276-7157, yisong.wang@nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI Omnibus R03 & R21 SEP-11.
Date: October 29, 2015.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Doubletree Hilton Hotel Bethesda, 8120 Wisconsin Avenue,
Bethesda, MD 20814.
Contact Person: Reed A. Graves, Ph.D., Scientific Review
Officer, Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W264, Rockville, MD 20850, 240-276-6384,
gravesr@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI Omnibus R03 & R21 SEP-3.
Date: November 5-6, 2015.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center, 5701
Marinelli Road, Bethesda, MD 20852.
Contact Person: Viatcheslav A. Soldatenkov, MD, Ph.D.,
Scientific Review Officer, Special Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W254, Bethesda, MD 20892, 240-276-6378,
soldatenkovv@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI Omnibus R03 & R21 SEP-1.
Date: November 9-10, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Doubletree Hilton Hotel Bethesda, 8120 Wisconsin Avenue,
Bethesda, MD 20814.
Contact Person: Zhiqiang Zou, MD, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W242, Bethesda, MD 20892-8328, 240-276-6372, zouzhiq@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: September 3, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-22659 Filed 9-8-15; 8:45 am]
BILLING CODE 4140-01-P